Inderpal Singh
General Counsel at IMMUNIC, INC.
Inderpal Singh active positions
| Companies | Position | Start | End |
|---|---|---|---|
| IMMUNIC, INC. | General Counsel | 2021-05-31 | - |
Career history of Inderpal Singh
Former positions of Inderpal Singh
| Companies | Position | Start | End |
|---|---|---|---|
Sandoz International GmbH
 Sandoz International GmbH Pharmaceuticals: GenericHealth Technology Sandoz International GmbH develops and manufactures generic pharmaceuticals. It produces finished dosage forms of such off-patent drugs as diabetes treatment Glucophage, GERD drug Prilosec, and cholesterol. The company was founded in 1996 and is headquartered in Holzkirchen, Austria. | Corporate Officer/Principal | 2017-12-31 | 2021-05-31 |
| MERCK KGAA | Corporate Officer/Principal | 2014-12-31 | 2016-12-31 |
Biogen International GmbH
 Biogen International GmbH Pharmaceuticals: MajorHealth Technology Biogen International GmbH produces pharmaceuticals. It develops medicines for psoriasis and multiple sclerosis. Its products include FUMADERM and BG-12. The company was founded in 1983 and is headquartered in Lucerne, Switzerland. | Corporate Officer/Principal | 2012-12-31 | 2014-12-31 |
Training of Inderpal Singh
| University of Mannheim | Masters Business Admin |
| Insead Business School | Masters Business Admin |
Statistics
International
| Germany | 4 |
| United States | 2 |
| France | 2 |
Operational
| Corporate Officer/Principal | 3 |
| Masters Business Admin | 2 |
| General Counsel | 1 |
Sectoral
| Health Technology | 5 |
| Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 2 |
|---|---|
| IMMUNIC, INC. | Health Technology |
| MERCK KGAA | Health Technology |
| Private companies | 2 |
|---|---|
Sandoz International GmbH
Sandoz International GmbH Pharmaceuticals: GenericHealth Technology Sandoz International GmbH develops and manufactures generic pharmaceuticals. It produces finished dosage forms of such off-patent drugs as diabetes treatment Glucophage, GERD drug Prilosec, and cholesterol. The company was founded in 1996 and is headquartered in Holzkirchen, Austria. | Health Technology |
Biogen International GmbH
Biogen International GmbH Pharmaceuticals: MajorHealth Technology Biogen International GmbH produces pharmaceuticals. It develops medicines for psoriasis and multiple sclerosis. Its products include FUMADERM and BG-12. The company was founded in 1983 and is headquartered in Lucerne, Switzerland. | Health Technology |
- Stock Market
- Insiders
- Inderpal Singh
- Experience
